{"id":4462,"count":2,"description":"Hyperthyroidism (overactive thyroid) most commonly caused by Graves' disease (autoimmune TSH-receptor antibody-mediated), toxic multinodular goitre, or solitary toxic adenoma. Symptoms include weight loss with normal\/increased appetite, palpitations, tremor, heat intolerance, anxiety, frequent stools, and (in Graves') eye signs (proptosis, lid lag, ophthalmopathy). The MedsBase Overactive Thyroid Treatment catalogue carries the antithyroid thionamide drugs that block thyroid peroxidase and reduce hormone synthesis.\n\n<strong>Rakt\u00e1ron l\u00e9v\u0151 opci\u00f3k.<\/strong> A metimazol (a modern el\u0151nyben r\u00e9szes\u00edtett tionamid \u2013 napi egyszeri adagol\u00e1s, kev\u00e9sb\u00e9 hepatotoxikus, mint a propiltiouracil, kiv\u00e9ve az els\u0151 trimeszterben \u00e9s thyreotoxikus kr\u00edzisben) k\u00e9szletben van mint <a href=\"https:\/\/medsbase.com\/hu\/methimez\/\">Methimez<\/a>. A karbimazol (a metimazol prodrugja, sz\u00e9les k\u00f6rben haszn\u00e1lt az UK\/Eur\u00f3pa\/India\/\u00c1zsia r\u00e9gi\u00f3ban) mint <a href=\"https:\/\/medsbase.com\/hu\/neomercazole\/\">Neomercazole<\/a>.\n\n<strong>Akut r\u00f6vid t\u00e1v\u00fa \u00e1lmatlans\u00e1g (id\u0151eltol\u00f3d\u00e1s, gy\u00e1sz, \u00e1tmeneti stressz) \u2014 melatonin 1\u20133 mg 30\u201360 perccel lefekv\u00e9s el\u0151tt 1\u20132 h\u00e9tig. K\u00e9sleltetett alv\u00e1sf\u00e1zis-zavar (k\u00fcl\u00f6n\u00f6sen serd\u00fcl\u0151kn\u00e9l \u00e9s m\u0171szakos dolgoz\u00f3kn\u00e1l) \u2014 melatonin 0,5\u20131 mg, 4\u20136 \u00f3r\u00e1val a k\u00edv\u00e1nt alv\u00e1skezd\u00e9s el\u0151tt. Kr\u00f3nikus \u00e1lmatlans\u00e1g (t\u00f6bb mint 3 h\u00f3nap) \u2014 els\u0151 vonalban CBT-I; gy\u00f3gyszeres lehet\u0151s\u00e9gek kiv\u00e1lasztott esetekben orvosi fel\u00fcgyelet mellett.<\/strong> Initial dose for moderate Graves' disease: methimazole 15\u201330 mg daily or carbimazole 20\u201340 mg daily, titrated based on TSH and free T4 measured every 4\u20136 weeks. Most patients achieve euthyroid state within 6\u201312 weeks. Long-term options: continue antithyroid drug for 12\u201318 months (40% remission rate after stopping in Graves'), radioactive iodine ablation (definitive but causes permanent hypothyroidism), or surgical thyroidectomy. Beta-blockers (propranolol \u2014 see <a href=\"https:\/\/medsbase.com\/hu\/heart-blood-pressure\/\">Sz\u00edv- \u00e9s v\u00e9rnyom\u00e1s<\/a>) a sz\u00edvdobog\u00e1s, remeg\u00e9s \u00e9s szorong\u00e1s t\u00fcneti kezel\u00e9s\u00e9re az antithyreoid gy\u00f3gyszer hat\u00e1s\u00e1nak megjelen\u00e9s\u00e9ig.\n\n<strong>Fontos.<\/strong> <strong>K\u00f6telez\u0151 el\u0151kezel\u00e9si alapv\u00e9rk\u00e9p \u00e9s m\u00e1jfunkci\u00f3s tesztek.<\/strong> Az antitiroid gy\u00f3gyszerek agranulocytosis-t okoznak a betegek 0,1\u20130,5%-\u00e1ban (jellemz\u0151en 90 napon bel\u00fcl, magasabb d\u00f3zisn\u00e1l nagyobb a kock\u00e1zat) \u2014 hirtelen l\u00e1z, torokf\u00e1j\u00e1s, sz\u00e1jfek\u00e9ly eset\u00e9n azonnali v\u00e9rk\u00e9p \u00e9s a kezel\u00e9s abbahagy\u00e1sa sz\u00fcks\u00e9ges, ha neutropenia \u00e1ll fenn. Hepatotoxicit\u00e1s \u2014 a propiltiouracil nagyobb kock\u00e1zatot jelent, mint a metimazol; m\u00e1jfunkci\u00f3s monitoroz\u00e1s sz\u00fcks\u00e9ges a kezel\u00e9s korai szakasz\u00e1ban. Terhess\u00e9g: az els\u0151 trimeszterben a propiltiouracil r\u00e9szes\u00edtend\u0151 el\u0151nyben (kev\u00e9sb\u00e9 teratog\u00e9n \u2014 a metimazol \u00e1ltal okozott aplasia cutis \u00e9s choanalis atr\u00e9zia), majd a m\u00e1sodik trimeszterben v\u00e1ltani kell metimazolra. A subakut thyroiditis hipertiroidizmussal jelenik meg, de NEM reag\u00e1l az antitiroid gy\u00f3gyszerekre (NSAID-k \u00e9s b\u00e9ta-blokkol\u00f3k alkalmazhat\u00f3k; a pajzsmirigy szcan seg\u00edt a differenci\u00e1l\u00e1sban). Minden MedsBase term\u00e9k <strong>WHO-GMP tan\u00fas\u00edtv\u00e1nnyal rendelkez\u0151 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmazik<\/strong> -b\u00f3l sz\u00e1ll\u00edtjuk, \u00e9s mindet fedezza <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\">\u00dajrak\u00fcld\u00e9si Garancia<\/a>.","link":"https:\/\/medsbase.com\/hu\/overactive-thyroid-treatment\/","name":"T\u00falm\u0171k\u00f6d\u0151 pajzsmirigy kezel\u00e9se","slug":"overactive-thyroid-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/4462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product?product_cat=4462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}